It is suggested that BV6, in combination with TRAIL and TNFα, inhibits the autophagy process, whereas TRAIL and TNFα treatment increases autophagy in MCF7 and MDA-MB-231 breast cancer cells. This evidence concerns the gene TNFSF10 and breast carcinoma.